US5082566A - Calcium-phosphate type hydroxyapatite for chromatographic separation and process for producing same - Google Patents

Calcium-phosphate type hydroxyapatite for chromatographic separation and process for producing same Download PDF

Info

Publication number
US5082566A
US5082566A US07/243,550 US24355088A US5082566A US 5082566 A US5082566 A US 5082566A US 24355088 A US24355088 A US 24355088A US 5082566 A US5082566 A US 5082566A
Authority
US
United States
Prior art keywords
hydroxyapatite
calcium
spherulites
phosphate
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US07/243,550
Inventor
Nobuaki Tagaya
Hideyuki Kuwahara
Takao Hashimoto
Noriko Komatsu
Keiko Fukamachi
Tsugio Maeshima
Toshihiro Ishikawa
Tetsuro Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pentax Corp
Original Assignee
Asahi Kogaku Kogyo Co Ltd
Toa Nenryo Kogyyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kogaku Kogyo Co Ltd, Toa Nenryo Kogyyo KK filed Critical Asahi Kogaku Kogyo Co Ltd
Priority to US07/731,567 priority Critical patent/US5217699A/en
Application granted granted Critical
Publication of US5082566A publication Critical patent/US5082566A/en
Assigned to TONEN CORPORATION, A CORP. OF JAPAN reassignment TONEN CORPORATION, A CORP. OF JAPAN CHANGE OF NAME AND CHANGE OF ADDRESS Assignors: TAO NENRYO KOGYO K.K.
Assigned to ASAHI OPTICAL CO., LTD., A/K/A ASAHI KOGAKU KOGYO KABUSHIKI KAISHA reassignment ASAHI OPTICAL CO., LTD., A/K/A ASAHI KOGAKU KOGYO KABUSHIKI KAISHA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TONEN CORPORATION
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/04Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of alkali metals, alkaline earth metals or magnesium
    • B01J20/048Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of alkali metals, alkaline earth metals or magnesium containing phosphorus, e.g. phosphates, apatites, hydroxyapatites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282Porous sorbents
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00Phosphorus; Compounds thereof
    • C01B25/16Oxyacids of phosphorus; Salts thereof
    • C01B25/26Phosphates
    • C01B25/32Phosphates of magnesium, calcium, strontium, or barium
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00Phosphorus; Compounds thereof
    • C01B25/16Oxyacids of phosphorus; Salts thereof
    • C01B25/26Phosphates
    • C01B25/32Phosphates of magnesium, calcium, strontium, or barium
    • C01B25/322Preparation by neutralisation of orthophosphoric acid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00Aspects relating to sorbent materials
    • B01J2220/50Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/54Sorbents specially adapted for analytical or investigative chromatography

Definitions

  • This invention relates to a calcium-phosphate type hydroxyapatite for chromatographic separation and a process for producing the same.
  • the invention is concerned with a novel calcium-phosphate type hydroxyapatite having specific crystal properties and useful as a column packing material for separation of biopolymers.
  • apatite-structure compounds is generically used to denote a large group of compounds having a common formula M 10 (ZO 4 ) 6 .X 2 where M represents a metallic atom of Ca, Ba, Sn, Mg, Na, K, Pb, Cd, Zn, Ni, Fe, Al or the like, ZO 4 represents an acid radical, such as PO 4 , AsO 4 , VO 4 , SO 4 , or SiO 4 , and X represents an OH or F atom (group).
  • M represents a metallic atom of Ca, Ba, Sn, Mg, Na, K, Pb, Cd, Zn, Ni, Fe, Al or the like
  • ZO 4 represents an acid radical, such as PO 4 , AsO 4 , VO 4 , SO 4 , or SiO 4
  • X represents an OH or F atom (group).
  • the present invention is directed to a calcium phosphate compound of the above general formula in which M is essentially Ca, ZO 4 essentially PO 4
  • hydroxyapatite The calcium-phosphate type hydroxyapatite, Ca 10 (PO 4 ) 6 (OH) 2 (hereinafter termed "hydroxyapatite” unless otherwise noted), has attracted growing attraction in recent years as a material for biomedical use, typically for artificial teeth and bones. This is because it closely resembles in composition to the inorganic ingredients of the teeth and bones of vertebrate animals and exhibits good affinity for living bodies. The affinity for living organisms has rendered it useful as a packing material to be filled in columns for chromatographic separation of biopolymers, for example, proteins, enzymes, and nucleic acids.
  • hydroxyapatites obtained in the foregoing processes have been in the form of plates which have to be finely divided particularly when used as column packing material for chromatographic separation.
  • the plates are thus divided into tiny pieces varied in shape and size.
  • the irregular pieces of hydroxyapatite cannot be packed uniformly or densely in the column for chromatographic separation.
  • the packing material so obtained can hardly be considered satisfactory in performance, both in separability and selectivity.
  • particle diameter refers to the diameter of the apatite "crystallite aggregate”. This differs from the “crystallite size" of the apatite.
  • crystallite means a micro-crystal. As the crystallite grows in size, the phrase “grain size” is substituted for the phrase “crystallite size” in the industry.
  • the hydroxyapatite prepared according to the present invention is in the form of spherulites having a mean "particle diameter" of 0.5 to 50 ⁇ m
  • the "crystallite size" of the present apatite ranges from between 0.01 to 0.05 ⁇ m (i.e., from 100 to 500 ⁇ ) wide and from 0.05 to 0.3 ⁇ m (i.e., from 500 to 3,000 ⁇ ) long.
  • the present invention is based upon these newly found facts.
  • the object of the invention is, in view of the fact that the hydroxyapatites proposed thus far have had inadequate separability and selectivity when used as column packing materials for chromatographic separation of biopolymers, to provide a novel calcium-phosphate type apatite for chromatographic separation having unique shape and size and excels in separability and selectivity.
  • this invention provides a calcium-phosphate type apatite for chromatographic separation taking the form of spherulites having a mean particle diameter of 0.5 to 50 ⁇ m, preferably 1 to 10 ⁇ m.
  • Such a hydroxyapatite can be satisfactorily produced by granulating a calcium-phosphate type hydroxyapatite in the form of a gel and then firing the granular apatite at a temperature in the range of 400° to 700° C.
  • FIGS. 1 to 3 are liquid chromatograms indicating that hydroxyapatites prepared in accordance with the invention are remarkably improved in separability over hydroxyapatites known in the art.
  • the present invention resides in a calcium-phosphate type hydroxyapatite for chromatographic separation in the form of spherulites having a mean particle diameter of 0.5 to 50 ⁇ m, preferably 1 to 10 ⁇ m.
  • a hydroxyapatite having crystal properties such that the crystal structure belongs to a series of hexagonal systems, with a space group of P6 3 /m and unit lattice constants of 9.58 ⁇ 0.08 ⁇ for the a axis and 7.00 ⁇ 0.05 ⁇ for the c axis, is capable of constantly achieving adequate separability and selectivity when used as a column packing material for chromatographic separation, especially of biopolymers.
  • unit lattice means a unit cell as a minimum repeating unit of crystal in which atoms, atomic groups, and molecules are regularly arranged in three-dimensional space.
  • the geometric symmetry of the unit cells is denoted by the crystal system and space group, and the size of the unit cells by the lattice constants.
  • the unit cell of apatite-structure compounds is represented by a hexagonal lattice, for example, with a Ca 2+ , PO 4 3- , or OH - arrangement therein.
  • the unit lattice constants of the already disclosed apatite-structure compounds for example, of the calcium-phosphate type hydroxyapatite, are 9.432 ⁇ for the a axis and 6.881 ⁇ for the c axis.
  • the hydroxyapatite as a preferred embodiment of the present invention has unit lattice constants of 9.58 ⁇ 0.08 ⁇ for the a axis and 7.00 ⁇ 0.05 ⁇ for the c axis.
  • the hydroxyapatite of the structure according to the invention is utterly dissimilar in crystal properties from those of the prior art and is a novel one not known in the art yet.
  • the unit lattice constants can be determined by the X-ray diffraction technique.
  • the angles of diffraction (Bragg angles) according to the powder X-ray diffraction are measured.
  • the diffraction angles can be obtained from the X-ray diffraction pattern recorded on a chart by an X-ray diffraction apparatus equipped with a diffractometer (using CuK ⁇ X-rays).
  • the crystal system of the hydroxyapatite is hexagonal, and Miller indices (hkl) are given for each lattice spacing d ( ⁇ ), as set forth in the powder X-ray diffraction file, JCPDS (Joint Committee on Powder Diffraction Standard) 9-432.
  • the lattice spacing d ( ⁇ ) is expressed, from the lattice constants a and c and from Miller indices (hkl), as formulated below: ##EQU1##
  • the unit lattice constants a and b of the hydroxyapatite as a preferred embodiment of the invention are found from the theoretical formula of the hexagonal system using the Bragg angles of the individual diffracted lines obtained by the X-ray diffractometry and the known Miller indices.
  • the most probable values and error ranges of the unit lattice constants a and c are determined by the method of least squares.
  • Table 1 shows the lattice spacings, d ( ⁇ ), obtained by the X-ray diffraction of the hydroxyapatite of the invention.
  • the hydroxyapatite as a preferred embodiment of the invention having the unit lattice constants of 9.58 ⁇ 0.08 ⁇ for the a axis and 7.00 ⁇ 0.05 ⁇ for the c axis exhibits particularly advantageous performance in the separation of biopolymers, for example, of proteins.
  • the separation performance is seriously low.
  • the grounds on which the hydroxyapatite of the invention having the unit lattice constants (a and c) within the specific ranges functions advantageously in the separation of biopolymers in particular are yet to be clarified.
  • a biopolymer for example, of a nucleic acid such as DNA or of a protein
  • an important role is played by the interactions between the adsorption points (adsorption sites) present in the hydroxyapatite substrate and the phosphoryl groups on the molecules of the nucleic acid or between the adsorption points and the amino and carboxyl groups of the protein.
  • adsorption points c adsorption points each constituted by two positively charged calcium atoms
  • adsorption points P adsorption points each constituted by six oxygen atoms derived from negatively charged phosphoryl ions. Located in the crystal, these points are arranged regularly and exist in a constant number per unit area. It follows that where the unit lattice constants a and c (values) are different, the distances between the adsorption points c and between the adsorption points P differ too.
  • the interactions between the adsorption points of the hydroxyapatite and the various functional groups of the biopolymers are important, and it is obvious that the distances between the adsorption points c and between the points P, or between those adsorption points influence the interactions such as adsorption or desorption of the biopolymers. Appropriate distances must be provided between these adsorption points. It is presumed that the hydroxyapatite having the unit lattice constants conforming to the present invention satisfies the foregoing conditions and performs excellently in the biopolymer separation.
  • the hydroxyapatite as a preferred embodiment of the invention having such unique crystal properties is desired to have such composition that the atomic ratio of Ca to P, or Ca/P, ranges from 1.5 to 1.9.
  • the hydroxyapatite of the invention useful as a column packing material for chromatographic separation exhibits a specific pyridine adsorption, in addition to the specific unit lattice constants as defined above.
  • Our investigations have revealed that a hydroxyapatite capable of adsorbing 0.003 to 0.01 mmol of pyridine per gram performs excellently in the separation of biopolymers.
  • the pyridine adsorption is expressed principally in terms of the solid acid amount based on the above-mentioned functional groups. If the pyridine adsorption is less than 0.003 mmol/g, the hydroxyapatite has a too low protein separation capability for practical service. If the pyridine adsorption exceeds 0.01 mmol/g, the separation performance is again inadequate.
  • the hydroxyapatite as a preferred embodiment of the invention takes the form of a crystallite aggregate consisting chiefly of tiny acicular crystals.
  • the dimensions are 100 to 500 ⁇ wide and 500 to 3000 ⁇ long.
  • the acicular crystallites are easy to granulate into spherulites in accordance with the invention, which are crystallite aggregates having a mean particle diameter of 0.5 to 50 ⁇ m, preferably 1 to 10 ⁇ m.
  • the granulation into spherulites brings with it the advantages of added mechanical strength and more uniform packing of the bed inside the separation column.
  • proteins capable of being separated by chromatography are immunoglobulin G, transterrin, myeloma immunoglobulin D, serum albumin, and ovalbumin.
  • the process of the invention may be carried out by firing the hydroxyapatite in the form of a gel or powder, obtained by the usual wet process involving a solution reaction, dry process involving a high-temperature, solid-phase reaction, or hydrothermal process involving hydrolysis as briefly outlined above, at a temperature of 400° to 700° C.
  • the process of the invention comprises granulating the hydroxyapatite in the form of a gel and then firing the granular hydroxyapatite at 400° to 700° C.
  • the hydroxyapatite in the form of a gel means a suspension or slurry in which acicular crystallites of hydroxyapatite are suspended or slurried with water or an aqueous solution containing the ions of calcium, phosphoric acid or the like. It can be prepared by any of the afore-described processes for hydroxyapatite synthesis. Also, a hydroxyapatite in the form of a gel may be obtained by dispersing or mixing powdered crystallites in an aqueous solution.
  • a desirable method of granulating the gel of hydroxyapatite is by spray drying.
  • the spray drying consists of spraying a hydroxyapatite suspension or slurry into a high-temperature air stream and thereby drying it up instantaneously.
  • the suspension or slurry concentration is 0.1 to 20% by weight, preferably 1 to 10% by weight
  • the temperature of the high-temperature air stream is 100° to 200° C., preferably 110° to 170° C.
  • the spray nozzle configurations, air quantity, and other conditions may be suitably chosen as desired.
  • the granulation yielded products with particle diameters controlled within the range of about 0.5 to about 50 ⁇ m, more particularly within the range of about 1 to about 20 ⁇ m. It was found possible that judicious granulation could afford spherulites with diameters in an even narrower range of about 1 to about 10 ⁇ m.
  • the firing is carried out by heating a hydroxyapatite in the form of a gel or powder in a heating zone to a predetermined temperature and then maintaining the same temperature level.
  • the firing temperature is in the range of 400° to 700° C., preferably in the range of 500° to 600° C.
  • the firing time is not critical but is usually 0.1 to 20 hours, preferably 1 to 3 hours. Desirably, the firing is carried out in the presence of oxygen or air.
  • the drying conditions are not specially limited but heating at 80° to 120° C. for 0.1 to 10 hours usually gives good result.
  • hydroxyapatite thus obtained by firing the starting apatite in the form of a gel in the manner described is a compound unknown in the art, novel with specific unit lattice constants and properties as follows:
  • a one-liter, three-necked flask was charged with a suspension of calcium hydroxide (consisting of 15.6 g 95% Ca(OH) 2 and 400 g distilled water). With the injection of nitrogen gas and with vigorous stirring, an aqueous solution of phosphoric acid (consisting of 13.8 g 85% H 3 PO 4 and 400 g distilled water) was slowly added. Following the conclusion of the addition, the pH was adjusted to 8.2 by the further addition of the aqueous phosphoric acid. The mixture was set in position on an oil bath and held at 90° C. for about 18 hours. A white crystallite-containing product, or a hydroxyapatite in the form of a gel, was obtained.
  • part of the product was passed through a spray drier to obtain spherical granules, or crystallite aggregates, about 1 to about 10 ⁇ m in diameter.
  • the product was further subjected to drying at 100° C. and firing at 580° C. to prepare granules for separation columns.
  • the lattice spacings found by X-ray diffraction of the granules are given in Table 1.
  • the property values of the granules were as follows:
  • a granulated hydroxyapatite 1 to 10 ⁇ m in particle diameter was lightly compacted by a pressure compactor.
  • the compact was ground in an agate mortar to a finer size of 30 to 100 meshes.
  • 0.075 g was exactly weighed and filled into a tubular sample tube, and dried in a nitrogen atmosphere at 100° C.
  • a bubbler containing pyridine was immersed in a water bath kept at a constant temperature of 15.5° C., and bubbling with nitrogen was carried out to allow the hydroxyapatite filled in the reactor to absorb the pyridine at 100° C. for 15 minutes. Thereafter, the temperature was gradually increased up to 200° C.
  • Example 1 The same material as used in Example 1 was employed to prepare granules under the same reaction conditions.
  • the granular product was dried at 100° C. and then fired at 400° C. for 3 hours.
  • the lattice spacings of the fired granules as measured by X-ray diffraction were as shown in Table 1.
  • Example 1 The same material and the same reaction conditions as used in Example 1 were employed to prepare granules.
  • the product was dried at 100° C. and fired at 700° C. for 3 hours.
  • the lattice spacings of the granules as measured by X-ray diffraction are given in Table 1.
  • the hydroxyapatites obtained in Examples 1 to 3 were used in separating samples of a mixture of cytochrome C, lysozyme, and bovine serum albumin (BSA).
  • the conditions employed for the chromatographic separating operations were as follows:
  • Liquid chromatograph Model "LC244" mfd. by Waters Co.
  • Solvent gradient solution: Aqueous solution of sodium phosphate (pH 6.8) 0.01-0.3 mol/hr gradient.
  • Sample quantity 100 ⁇ l each (50 ⁇ l where the hydroxyapatite of Example 2 was used).
  • the hydroxyapatite according to the present invention has unique shape, size, and crystal properties and is extremely useful as a column packing material for chromatographic separation of biopolymers, for example, proteins, realizing marked improvements in the separability of chromatography.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

A calcium-phosphate type hydroxyapatite for chromatographic separation is in the form of spherulites having a mean particle diameter of 0.5 to 50 μm, preferably 1 to 10 μm. The spherulites are each an aggregate mainly of acicular crystallites belonging to a series of hexagonal systems and having unit lattice constants of 9.58±0.08 Å for the a axis and 7.00±0.05 Å for the c axis. The hydroxyapatite is produced by granulating a calcium-phosphate type hydroxyapatite in the form of a gel and then firing the granular apatite at 400° to 700° C., preferably at 500° to 600° C. The firing is performed by heating the granules in the presence of oxygen or air for a given period of time.

Description

This is a divisional of co-pending application Ser. No. 909,978 filed on 9/22/86, now U.S. Pat. No. 4,781,904.
BACKGROUND OF THE INVENTION
This invention relates to a calcium-phosphate type hydroxyapatite for chromatographic separation and a process for producing the same.
More particularly, the invention is concerned with a novel calcium-phosphate type hydroxyapatite having specific crystal properties and useful as a column packing material for separation of biopolymers.
The term apatite-structure compounds is generically used to denote a large group of compounds having a common formula M10 (ZO4)6.X2 where M represents a metallic atom of Ca, Ba, Sn, Mg, Na, K, Pb, Cd, Zn, Ni, Fe, Al or the like, ZO4 represents an acid radical, such as PO4, AsO4, VO4, SO4, or SiO4, and X represents an OH or F atom (group). The present invention is directed to a calcium phosphate compound of the above general formula in which M is essentially Ca, ZO4 essentially PO4, and X essentially OH.
The calcium-phosphate type hydroxyapatite, Ca10 (PO4)6 (OH)2 (hereinafter termed "hydroxyapatite" unless otherwise noted), has attracted growing attraction in recent years as a material for biomedical use, typically for artificial teeth and bones. This is because it closely resembles in composition to the inorganic ingredients of the teeth and bones of vertebrate animals and exhibits good affinity for living bodies. The affinity for living organisms has rendered it useful as a packing material to be filled in columns for chromatographic separation of biopolymers, for example, proteins, enzymes, and nucleic acids.
Conventionally, such hydroxyapatites are synthesized in most cases by
(1) wet synthesis involving an aqueous solution reaction in which a water-soluble calcium salt and phosphate are allowed to react in aqueous solution,
(2) dry synthesis involving a high-temperature solid-phase reaction in which calcium phosphate and calcium carbonate are allowed to react in the presence of water vapor at 900° to 1400° C., or
(3) hydrothermal synthesis involving a reaction under high-temperature, high-pressure steam in which calcium hydrogen-phosphate is hydrolyzed, for example, at 200° C. and at 15 atm.
In addition to these, a new synthetic process has been proposed, for example, by Patent Application Publication No. 500447/1980.
The hydroxyapatites obtained in the foregoing processes have been in the form of plates which have to be finely divided particularly when used as column packing material for chromatographic separation.
The plates are thus divided into tiny pieces varied in shape and size. The irregular pieces of hydroxyapatite cannot be packed uniformly or densely in the column for chromatographic separation. The packing material so obtained can hardly be considered satisfactory in performance, both in separability and selectivity.
In an effort to overcome the difficulties of the conventional hydroxyapatites as column packing materials for chromatographic separation, we have made extensive studies and experiments. As a result, it has now been found that, when such a hydroxyapatite is employed as a packing material for chromatographic separation, the size and shape of the finely divided product constitute very important factors and that, in particular, the shape should be spherical and the size distribution be within a narrow range, and further that the hydroxyapatite in the form of spherulites having a mean particle diameter of 0.5 to 50 μm, preferably 1 to 10 μm, achieves adequate separability and selectivity.
The term "particle diameter" as used herein refers to the diameter of the apatite "crystallite aggregate". This differs from the "crystallite size" of the apatite.
The term "crystallite" means a micro-crystal. As the crystallite grows in size, the phrase "grain size" is substituted for the phrase "crystallite size" in the industry.
While the hydroxyapatite prepared according to the present invention is in the form of spherulites having a mean "particle diameter" of 0.5 to 50 μm, the "crystallite size" of the present apatite ranges from between 0.01 to 0.05 μm (i.e., from 100 to 500 Å) wide and from 0.05 to 0.3 μm (i.e., from 500 to 3,000 Å) long.
The present invention is based upon these newly found facts.
Therefore, the object of the invention is, in view of the fact that the hydroxyapatites proposed thus far have had inadequate separability and selectivity when used as column packing materials for chromatographic separation of biopolymers, to provide a novel calcium-phosphate type apatite for chromatographic separation having unique shape and size and excels in separability and selectivity.
SUMMARY OF THE INVENTION
Briefly, this invention provides a calcium-phosphate type apatite for chromatographic separation taking the form of spherulites having a mean particle diameter of 0.5 to 50 μm, preferably 1 to 10 μm.
Such a hydroxyapatite can be satisfactorily produced by granulating a calcium-phosphate type hydroxyapatite in the form of a gel and then firing the granular apatite at a temperature in the range of 400° to 700° C.
BRIEF DESCRIPTION OF THE DRAWINGS
FIGS. 1 to 3 are liquid chromatograms indicating that hydroxyapatites prepared in accordance with the invention are remarkably improved in separability over hydroxyapatites known in the art.
DETAILED DESCRIPTION OF THE INVENTION
The present invention resides in a calcium-phosphate type hydroxyapatite for chromatographic separation in the form of spherulites having a mean particle diameter of 0.5 to 50 μm, preferably 1 to 10 μm. Our further research has now revealed that a hydroxyapatite having crystal properties such that the crystal structure belongs to a series of hexagonal systems, with a space group of P63 /m and unit lattice constants of 9.58±0.08 Å for the a axis and 7.00±0.05 Å for the c axis, is capable of constantly achieving adequate separability and selectivity when used as a column packing material for chromatographic separation, especially of biopolymers.
The hydroxyapatite having the desirable, unique crystal properties will now be described in detail below.
As used herein, the term "unit lattice" means a unit cell as a minimum repeating unit of crystal in which atoms, atomic groups, and molecules are regularly arranged in three-dimensional space. The geometric symmetry of the unit cells is denoted by the crystal system and space group, and the size of the unit cells by the lattice constants. The unit cell of apatite-structure compounds is represented by a hexagonal lattice, for example, with a Ca2+, PO4 3-, or OH- arrangement therein.
The unit lattice constants of the already disclosed apatite-structure compounds, for example, of the calcium-phosphate type hydroxyapatite, are 9.432 Å for the a axis and 6.881 Å for the c axis.
The hydroxyapatite as a preferred embodiment of the present invention, by contrast, has unit lattice constants of 9.58±0.08 Å for the a axis and 7.00±0.05 Å for the c axis. Thus, the hydroxyapatite of the structure according to the invention is utterly dissimilar in crystal properties from those of the prior art and is a novel one not known in the art yet.
The unit lattice constants can be determined by the X-ray diffraction technique. To be more concrete, the angles of diffraction (Bragg angles) according to the powder X-ray diffraction are measured. The diffraction angles can be obtained from the X-ray diffraction pattern recorded on a chart by an X-ray diffraction apparatus equipped with a diffractometer (using CuKα X-rays). Also, from the Bragg equation λ=2α sin θ(where λ is the wavelength of the CuKα rays, 1.54184 Å) the lattice spacings in angstroms, d (Å), can be found. The crystal system of the hydroxyapatite is hexagonal, and Miller indices (hkl) are given for each lattice spacing d (Å), as set forth in the powder X-ray diffraction file, JCPDS (Joint Committee on Powder Diffraction Standard) 9-432. The lattice spacing d (Å) is expressed, from the lattice constants a and c and from Miller indices (hkl), as formulated below: ##EQU1##
Using the Bragg equation, it is written as: ##EQU2##
The unit lattice constants a and b of the hydroxyapatite as a preferred embodiment of the invention are found from the theoretical formula of the hexagonal system using the Bragg angles of the individual diffracted lines obtained by the X-ray diffractometry and the known Miller indices. The most probable values and error ranges of the unit lattice constants a and c are determined by the method of least squares. Table 1 shows the lattice spacings, d (Å), obtained by the X-ray diffraction of the hydroxyapatite of the invention.
The hydroxyapatite as a preferred embodiment of the invention having the unit lattice constants of 9.58±0.08 Å for the a axis and 7.00±0.05 Å for the c axis exhibits particularly advantageous performance in the separation of biopolymers, for example, of proteins. When the unit lattice constants of the apatite are not within the ranges specified above, the separation performance is seriously low.
The grounds on which the hydroxyapatite of the invention having the unit lattice constants (a and c) within the specific ranges functions advantageously in the separation of biopolymers in particular are yet to be clarified. However, it may well be said that, ordinarily in the separation of a biopolymer, for example, of a nucleic acid such as DNA or of a protein, an important role is played by the interactions between the adsorption points (adsorption sites) present in the hydroxyapatite substrate and the phosphoryl groups on the molecules of the nucleic acid or between the adsorption points and the amino and carboxyl groups of the protein.
It is to be noted here that on the surface of the hydroxyapatite there appear mainly two different planes; one parallel to the plane ac or bc of the crystal lattice (and called the plane b or a, respectively) which are equivalent crystallographically, and a plane parallel to the plane ab (and called the plane c). On the plane a or b of the crystal are arranged adsorption points (called the adsorption points c) each constituted by two positively charged calcium atoms, and on the plane c of the crystal, adsorption points (called the points P) each constituted by six oxygen atoms derived from negatively charged phosphoryl ions. Located in the crystal, these points are arranged regularly and exist in a constant number per unit area. It follows that where the unit lattice constants a and c (values) are different, the distances between the adsorption points c and between the adsorption points P differ too.
As noted above, for the chromatographic separation of biopolymers the interactions between the adsorption points of the hydroxyapatite and the various functional groups of the biopolymers are important, and it is obvious that the distances between the adsorption points c and between the points P, or between those adsorption points influence the interactions such as adsorption or desorption of the biopolymers. Appropriate distances must be provided between these adsorption points. It is presumed that the hydroxyapatite having the unit lattice constants conforming to the present invention satisfies the foregoing conditions and performs excellently in the biopolymer separation.
The hydroxyapatite as a preferred embodiment of the invention having such unique crystal properties is desired to have such composition that the atomic ratio of Ca to P, or Ca/P, ranges from 1.5 to 1.9.
The hydroxyapatite of the invention useful as a column packing material for chromatographic separation exhibits a specific pyridine adsorption, in addition to the specific unit lattice constants as defined above. Our investigations have revealed that a hydroxyapatite capable of adsorbing 0.003 to 0.01 mmol of pyridine per gram performs excellently in the separation of biopolymers. This is presumably ascribable to the control of the acid amount, particularly of the functional group OH-, among the functional groups OH-, Ca2+, and PO4 3- that play vital roles in the interactions between the hydroxyapatite substrate and the phosphoryl groups on the nucleic acid or between the substrate and the amino and carboxyl groups of the protein as described above.
The pyridine adsorption is expressed principally in terms of the solid acid amount based on the above-mentioned functional groups. If the pyridine adsorption is less than 0.003 mmol/g, the hydroxyapatite has a too low protein separation capability for practical service. If the pyridine adsorption exceeds 0.01 mmol/g, the separation performance is again inadequate.
The hydroxyapatite as a preferred embodiment of the invention takes the form of a crystallite aggregate consisting chiefly of tiny acicular crystals. The dimensions are 100 to 500 Å wide and 500 to 3000 Å long. The acicular crystallites are easy to granulate into spherulites in accordance with the invention, which are crystallite aggregates having a mean particle diameter of 0.5 to 50 μm, preferably 1 to 10 μm. The granulation into spherulites brings with it the advantages of added mechanical strength and more uniform packing of the bed inside the separation column.
Examples of the proteins capable of being separated by chromatography are immunoglobulin G, transterrin, myeloma immunoglobulin D, serum albumin, and ovalbumin.
The process for producing the hydroxyapatite in accordance with the present invention will now be described.
The process of the invention may be carried out by firing the hydroxyapatite in the form of a gel or powder, obtained by the usual wet process involving a solution reaction, dry process involving a high-temperature, solid-phase reaction, or hydrothermal process involving hydrolysis as briefly outlined above, at a temperature of 400° to 700° C. Preferably, the process of the invention comprises granulating the hydroxyapatite in the form of a gel and then firing the granular hydroxyapatite at 400° to 700° C.
We have extensively studied about the relationship between the crystal properties of apatite-structure compounds and the firing temperatures. As a result, it has been found that the unit lattice constants of the apatite-structure compounds increase with the rise of the firing temperature, to a maximum at a point short of about 600° C. and then turn for decreases with the further rise of the temperature beyond that point. The present invention is predicated upon this discovery.
The expression "the hydroxyapatite in the form of a gel" as used herein means a suspension or slurry in which acicular crystallites of hydroxyapatite are suspended or slurried with water or an aqueous solution containing the ions of calcium, phosphoric acid or the like. It can be prepared by any of the afore-described processes for hydroxyapatite synthesis. Also, a hydroxyapatite in the form of a gel may be obtained by dispersing or mixing powdered crystallites in an aqueous solution.
A desirable method of granulating the gel of hydroxyapatite is by spray drying. The spray drying consists of spraying a hydroxyapatite suspension or slurry into a high-temperature air stream and thereby drying it up instantaneously. As for the conditions for spray drying, the suspension or slurry concentration is 0.1 to 20% by weight, preferably 1 to 10% by weight, and the temperature of the high-temperature air stream is 100° to 200° C., preferably 110° to 170° C. The spray nozzle configurations, air quantity, and other conditions may be suitably chosen as desired. Experiments showed that the granulation yielded products with particle diameters controlled within the range of about 0.5 to about 50 μm, more particularly within the range of about 1 to about 20 μm. It was found possible that judicious granulation could afford spherulites with diameters in an even narrower range of about 1 to about 10 μm.
In the process of the invention, the firing is carried out by heating a hydroxyapatite in the form of a gel or powder in a heating zone to a predetermined temperature and then maintaining the same temperature level. The firing temperature is in the range of 400° to 700° C., preferably in the range of 500° to 600° C. The firing time is not critical but is usually 0.1 to 20 hours, preferably 1 to 3 hours. Desirably, the firing is carried out in the presence of oxygen or air. The drying conditions are not specially limited but heating at 80° to 120° C. for 0.1 to 10 hours usually gives good result.
The hydroxyapatite thus obtained by firing the starting apatite in the form of a gel in the manner described is a compound unknown in the art, novel with specific unit lattice constants and properties as follows:
______________________________________                                    
Particle diameter, in μm                                               
                 0.5-50                                                   
Ca/P ratio       1.5-1.9                                                  
Particle shape   spherical (acicular-                                     
                 crystallite aggregates)                                  
Pyridine adsorption,                                                      
                 0.003-0.01                                               
in mmol/g                                                                 
______________________________________                                    
Next, the present invention is illustrated by the following examples.
EXAMPLE 1
A one-liter, three-necked flask was charged with a suspension of calcium hydroxide (consisting of 15.6 g 95% Ca(OH)2 and 400 g distilled water). With the injection of nitrogen gas and with vigorous stirring, an aqueous solution of phosphoric acid (consisting of 13.8 g 85% H3 PO4 and 400 g distilled water) was slowly added. Following the conclusion of the addition, the pH was adjusted to 8.2 by the further addition of the aqueous phosphoric acid. The mixture was set in position on an oil bath and held at 90° C. for about 18 hours. A white crystallite-containing product, or a hydroxyapatite in the form of a gel, was obtained.
After cooling, part of the product was passed through a spray drier to obtain spherical granules, or crystallite aggregates, about 1 to about 10 μm in diameter.
The product was further subjected to drying at 100° C. and firing at 580° C. to prepare granules for separation columns. The lattice spacings found by X-ray diffraction of the granules are given in Table 1. The property values of the granules were as follows:
(1) Unit lattice constants determined by X-ray diffraction:
a=9.58 Å
c=7.01 Å
(2) Pyridine absorption=0.0056 mmol/g
(3) Ca/P ratio=1.67
X-ray diffraction was carried out using the apparatus manufactured by Rigaku Denki Co., Model "RAD-rD". The measurement conditions employed were as follows:
Output=40 kV, 30 mA CuKα
DS/RS/SS=1/6° C./0.15 mm/1/6° C.
Preset time=0.1 sec.
Step width=1/100
              TABLE 1                                                     
______________________________________                                    
Miller                                                                    
indices  Lattice spacing d (Å)                                        
h · k · l                                               
         Ex. 1         Ex. 2   Ex. 3                                      
______________________________________                                    
002      3.503         3.480   3.495                                      
102      3.227         3.206   3.219                                      
210      3.137         3.113   3.126                                      
211      2.863         2.842   2.854                                      
112      2.828         2.808   2.820                                      
300      2.767         2.745   2.757                                      
202      2.677         2.658   2.669                                      
301      2.573         2.554   2.565                                      
212      2.337         2.320   2.330                                      
310      2.302         2.284   2.294                                      
222      1.778         1.963   1.971                                      
312      1.924         1.910   1.918                                      
213      1.873         1.860   1.868                                      
______________________________________                                    
Pyridine absorption was determined in the following way.
A granulated hydroxyapatite 1 to 10 μm in particle diameter was lightly compacted by a pressure compactor. The compact was ground in an agate mortar to a finer size of 30 to 100 meshes. Of the ground apatite, 0.075 g was exactly weighed and filled into a tubular sample tube, and dried in a nitrogen atmosphere at 100° C. Meanwhile, a bubbler containing pyridine was immersed in a water bath kept at a constant temperature of 15.5° C., and bubbling with nitrogen was carried out to allow the hydroxyapatite filled in the reactor to absorb the pyridine at 100° C. for 15 minutes. Thereafter, the temperature was gradually increased up to 200° C. in a nitrogen stream, and the temperature was maintained to cause desorption of the physically absorbed content. By gas chromatography of the hydrogen ion detection type, it was confirmed that no more desorption of pyridine was detectable. Next, the temperature was increased at a rate of 5° C./minute from 200° C. up to 950° C. The quantity of pyridine desorbed thereby was determined by the gas chromatography. This quantity of pyridine eliminated was measured as the pyridine absorption.
EXAMPLE 2
The same material as used in Example 1 was employed to prepare granules under the same reaction conditions. The granular product was dried at 100° C. and then fired at 400° C. for 3 hours. The lattice spacings of the fired granules as measured by X-ray diffraction were as shown in Table 1.
The property values of the product were as follows:
(1) Unit lattice constants:
a=9.51 Å
c=6.96 Å
(2) Pyridine adsorption=0.0092 mmol/g
(3) Ca/P ratio=1.67
EXAMPLE 3
The same material and the same reaction conditions as used in Example 1 were employed to prepare granules. The product was dried at 100° C. and fired at 700° C. for 3 hours. The lattice spacings of the granules as measured by X-ray diffraction are given in Table 1.
The property values were as follows:
(1) Unit lattice constants:
a=9.55 Å
c=6.99 Å
(2) Pyridine adsorption=0.0038 mmol/g
(3) Ca/P ratio=1.67
REFERENCE EXAMPLE
The hydroxyapatites obtained in Examples 1 to 3 were used in separating samples of a mixture of cytochrome C, lysozyme, and bovine serum albumin (BSA). The conditions employed for the chromatographic separating operations were as follows:
Liquid chromatograph: Model "LC244" mfd. by Waters Co.
Solvent (gradient solution): Aqueous solution of sodium phosphate (pH 6.8) 0.01-0.3 mol/hr gradient.
Flow rate: 0.8 ml/min.
Sample quantity: 100 μl each (50 μl where the hydroxyapatite of Example 2 was used).
Detector: Model "UVDEC-100-III"mfd. by Japan Spectroscopic Co. Detection wavelength=280 nm.
Chromatogram record: Recording chart speed=2.5 mm/min.
The results are graphically shown in FIGS. 1 to 3. It can be clearly seen that the hydroxyapatites prepared in accordance with the invention have by far the greater separation capabilities than the known hydroxyapatites.
Numbers of theoretical plates were found so as to determine the separation capabilities in the separation of cytochrome C. The results obtained are shown in Table 2. For the purposes of the invention the term "number of theoretical plates" is calculated, on the basis of the resolution time (tR) in chromatography and the half-width of the chromatograph, from the following formula:
N(No. of theoretical plates)=16(tR/ω).sup.2.
              TABLE 2                                                     
______________________________________                                    
           Example                                                        
           1         2       3                                            
______________________________________                                    
Ca/P ratio                           1.67                                 
Lattice                                                                   
spacing constant                                                          
a (Å)          9.58        9.51  9.55                                 
c (Å)          7.01        6.96  6.99                                 
Pyridine           0.0056      0.0092                                     
                                     0.0038                               
adsorption                                                                
(mmol/g)                                                                  
No. of theo-                                                              
retical plates     14,000      13,000                                     
                                     11,000                               
for separation                                                            
of cytochrome C    20,000                                                 
______________________________________                                    
The hydroxyapatite according to the present invention has unique shape, size, and crystal properties and is extremely useful as a column packing material for chromatographic separation of biopolymers, for example, proteins, realizing marked improvements in the separability of chromatography.

Claims (25)

What is claimed is:
1. A process comprising using a calcium-phosphate hydroxyapatite as a column packing material for chromatographic separation wherein said hydroxyapatite is in the form of spherulites having a mean particle diameter of 0.5 to 50 μm, and wherein said spherulites are formed by granulating calcium-phosphate type hydroxyapatite crystallites to make apatite crystallite aggregates, each said crystallite of the aggregates having a size ranging from 0.01 to 0.05 μm wide and from 0.05 to 0.3 μm long, and then firing the crystallite aggregates at a temperature in the range of 400° C. to 700° C.
2. A process in accordance with claim 1 wherein said hydroxyapatite is in the form of spherulites having a mean particle diameter of 1 to 10 μm.
3. A process in accordance with claim 1 wherein said hydroxyapatite has a pyridine absorption capability which is in the range of 0.003 to 0.01 mmol/g.
4. A process in accordance with claim 3 wherein the Ca/P ratio of said hydroxyapatite is in the range of 1.50 to 1.90.
5. A process comprising using a calcium-phosphate as a column packing material for chromatographic separation, wherein said hydroxyapatite comprises spherulites having a mean particle diameter of 0.5-50 μm, wherein said spherulites are prepared by granulating a calcium-phosphate type hydroxyapatite in the form of a gel to make apatite crystallite aggregates, each said crystallite of the aggregates having a size ranging from 0.01 to 0.05 μm wide and from 0.05 to 0.3 μm long, and then firing the crystallite aggregates at a temperature in the range of 400° C. to 700° C.
6. A process according to claim 5 which the firing temperature is in the range of 500° C. to 600° C.
7. A process according to claim 5 wherein firing of the granular calcium-phosphate type hydroxyapatite is performed by heating the granules in the presence of oxygen or air for a given period of time.
8. A process according to claim 7 in which the mean particle diameter of the granules is 1 to 10 μm.
9. A column for chromatographic separations, at least partially filled with a packing material, wherein said packing material comprises a calcium-phosphate hydroxyapatite in the form of spherulites having a mean particle diameter of 0.5 to 50 microns, and wherein said spherulites are formed by granulating calcium-phosphate type hydroxyapatite crystallites to make apatite crystallite aggregates, each said crystallite of the aggregates having a size ranging from 0.01 to 0.05 microns wide and from 0.05 to 0.3 microns long, and then firing the crystallite aggregates at a temperature in the range of 400° C. to about 700° C.
10. A column in accordance with claim 9, wherein the mean particle diameter of the calcium-phosphate hydroxyapatite spherulites is 1 to 10 μm.
11. A column in accordance with claim 9, wherein the absorption of pyridene, by said packing material is in the range of 0.003 to 0.01 mmol/g.
12. A column in accordance with claim 9, wherein the Ca/P ratio of said calcium-phosphate hydroxyapatite is in the range of 1.5:1 to 1.9:1.
13. A column in accordance with claim 9, wherein said calcium-phosphate hydroxyapatite is prepared by granulating a calcium-phosphate type hydroxyapatite having acicular crystallites in the form of a gel to form spherulites, each spherulite being formed by aggregating mainly acicular crystallites and then firing the granular crystallites that a temperature in the range of 400° C. to 700° C.
14. A column in accordance with claim 9, wherein said calcium-phosphate hydroxyapatite is formed by firing granular calcium-phosphate type hydroxyapatite at a temperature in the range of 500° C. to 600° C.
15. A column in accordance with claim 9, wherein said calcium-phosphate hydroxyapatite is formed by heating said calcium-phosphate type hydroxyapatite in the presence of oxygen or air for a given period of time.
16. A process comprising using a calcium-phosphate hydroxyapatite as a column packing material for chromatographic separation wherein said hydroxyapatite is in the form of spherulites having a mean particle diameter of 0.5 to 50 μm and a crystallite size ranging from 0.01 to 0.05 μm wide and from 0.05 to 0.3 μm long.
17. A process in accordance with claim 16 wherein said spherulites are formed by firing a granular calcium-phosphate type hydroxyapatite, said hydroxyapatite having mainly acicular crystallites.
18. A process comprising using a calcium-phosphate hydroxyapatite as a column packing material for chromatographic separation, wherein said hydroxyapatite comprises spherulites having a mean particle diameter of 0.5 to 50 μm, and wherein said spherulites are prepared by granulating a calcium-phosphate hydroxyapatite in the form of a gel to make apatite crystallite aggregates, each said crystallite of the aggregates having a size ranging from 0.01 to 0.05 μm wide and from 0.05 to 0.3 μm long.
19. A process in accordance with claim 18 wherein each spherulite is formed by aggregating mainly acicular crystallites and then firing the granular crystallites.
20. A process in accordance with claim 16 wherein said spherulites have a mean particle diameter of 1 to 10 μm.
21. A column for chromatographic separation, at least partially filled with a packing material, wherein said packing material comprises a calcium-phosphate hydroxyapatite in the form of spherulites having a mean particle diameter of 0.5 to 50 μm and a crystallite size ranging from 0.01 to 0.05 μm wide and from 0.05 to 0.3 μm long.
22. A column in accordance with claim 21 wherein said spherulites are formed by firing a granular calcium-phosphate hydroxyapatite, said hydroxyapatite having mainly acicular crystallites.
23. A column in accordance with claim 21 wherein said calcium-phosphate hydroxyapatite is prepared by granulating a calcium-phosphate type hydroxyapatite having acicular crystallites in the form of a gel to form said spherulites.
24. A column in accordance with claim 23 wherein each spherulite is formed by aggregating mainly acicular crystallites and then firing the granular crystallites.
25. A column in accordance with claim 21 wherein said spherulites have a mean particle diameter of 1 to 10 μm.
US07/243,550 1985-09-23 1988-09-12 Calcium-phosphate type hydroxyapatite for chromatographic separation and process for producing same Expired - Lifetime US5082566A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/731,567 US5217699A (en) 1985-09-23 1991-07-17 Calcium-phosphate type hydroxyapatite

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60209562A JPH0788205B2 (en) 1985-09-23 1985-09-23 Chromatography-separation calcium phosphate-based hydroxyapatite and method for producing the same
JP60-209561 1985-09-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US06/909,978 Division US4781904A (en) 1985-09-23 1986-09-22 Calcium-phosphate type hydroxyapatite for chromatographic separation and process for producing same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US07/731,567 Continuation US5217699A (en) 1985-09-23 1991-07-17 Calcium-phosphate type hydroxyapatite

Publications (1)

Publication Number Publication Date
US5082566A true US5082566A (en) 1992-01-21

Family

ID=16574881

Family Applications (2)

Application Number Title Priority Date Filing Date
US06/909,978 Expired - Lifetime US4781904A (en) 1985-09-23 1986-09-22 Calcium-phosphate type hydroxyapatite for chromatographic separation and process for producing same
US07/243,550 Expired - Lifetime US5082566A (en) 1985-09-23 1988-09-12 Calcium-phosphate type hydroxyapatite for chromatographic separation and process for producing same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US06/909,978 Expired - Lifetime US4781904A (en) 1985-09-23 1986-09-22 Calcium-phosphate type hydroxyapatite for chromatographic separation and process for producing same

Country Status (8)

Country Link
US (2) US4781904A (en)
EP (1) EP0217614B1 (en)
JP (1) JPH0788205B2 (en)
KR (1) KR910006420B1 (en)
CN (1) CN1013663B (en)
AT (1) ATE56198T1 (en)
AU (1) AU595238B2 (en)
DE (1) DE3673934D1 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827669A (en) * 1995-11-10 1998-10-27 Mikio Nakayama Sheets, kits and methods for detecting antigens or antibodies
US5843731A (en) * 1996-09-05 1998-12-01 Asahi Kogaku Kogyo Kabushiki Kaisha Method for purifying plasmid DNA on calcium phosphate compound
US5858318A (en) * 1996-11-27 1999-01-12 Luo; Ping Methods of synthesizing hydroxyapatite powders and bulk materials
US5910584A (en) * 1996-09-05 1999-06-08 Asahi Kogaku Kogyo Kabushiki Kaisha Method for isolating plasmid DNA
US6203574B1 (en) 1998-04-14 2001-03-20 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic bone filler and process for the production of the same
US20050123652A1 (en) * 2003-12-04 2005-06-09 Kuzma William M. Method for producing tri-calcium phosphate
US20080221681A1 (en) * 2007-03-09 2008-09-11 Warsaw Orthopedic, Inc. Methods for Improving Fatigue Performance of Implants With Osteointegrating Coatings
US20080221688A1 (en) * 2007-03-09 2008-09-11 Warsaw Orthopedic, Inc. Method of Maintaining Fatigue Performance In A Bone-Engaging Implant
US20100040668A1 (en) * 2006-01-12 2010-02-18 Rutgers, The State University Of New Jersey Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
US20100189611A1 (en) * 2006-08-23 2010-07-29 The Clorox Company Foamable Composition Containing Alcohol
WO2011060099A2 (en) 2009-11-10 2011-05-19 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles, and methods of making and using the same
US8287914B2 (en) 2006-01-12 2012-10-16 Rutgers, The State University Of New Jersey Biomimetic hydroxyapatite synthesis
CN103191705A (en) * 2013-04-15 2013-07-10 武汉大学 Preparation method of open tubular capillary electrochromatographic column
US8815328B2 (en) 2005-01-04 2014-08-26 Rutgers, The State University Of New Jersey Hydroxyapatite with controllable size and morphology
US20180209947A1 (en) * 2014-03-03 2018-07-26 Bioway Scientific Llc Spherical porous hydroxyapatite sorbent and methods thereof
EP4218718A2 (en) 2009-05-06 2023-08-02 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441635A (en) * 1986-07-05 1995-08-15 Asahi Kogaku Kogyo Kabushiki Kaisha Packing material for liquid chromatography
US5039408A (en) * 1986-07-05 1991-08-13 Asahi Kogaku Kogyo K.K. Packing material for liquid chromatography
JPS6413453A (en) * 1987-07-08 1989-01-18 Asahi Optical Co Ltd Packing agent for liquid chromatography
US6306297B1 (en) 1968-07-08 2001-10-23 Asahi Kogaku Kogyo Kabushiki Kaisha Packing material for liquid chromatography and process for producing the same
US5217699A (en) * 1985-09-23 1993-06-08 Toa Nenryo Kogyo Kabushiki Kaisha Calcium-phosphate type hydroxyapatite
JPH0762674B2 (en) * 1986-03-07 1995-07-05 株式会社高研 Chromatographic adsorbent, method for producing the same, and chromatographic column using the adsorbent
EP0239970A3 (en) * 1986-03-31 1988-04-20 Toa Nenryo Kogyo Kabushiki Kaisha Assemblage of hydroxyl apatite particles and liquid chromatography column using the same
USRE35340E (en) * 1986-07-05 1996-10-01 Asahi Kogaku Kogyo K.K. Packing material for liquid chromatography
JPH0796445B2 (en) * 1986-09-02 1995-10-18 東燃株式会社 Hydroxyapatite secondary particle aggregate, method for producing the same, and use thereof as a chromatographic filler
DE3709897A1 (en) * 1987-03-26 1988-10-06 Ewers Rolf METHOD OF MANUFACTURING A HYDROXYLAPATITE MATERIAL
JPH0620537B2 (en) * 1987-06-22 1994-03-23 株式会社サンギ Adsorbent using hydroxyapatite
DE3888079T2 (en) * 1987-10-22 1994-07-14 Asahi Optical Co Ltd Porous ceramic material.
JPH01155263A (en) * 1987-12-12 1989-06-19 Asahi Optical Co Ltd Filler for liquid chromatography and preparation thereof
US4849193A (en) * 1988-05-02 1989-07-18 United States Gypsum Company Process of preparing hydroxylapatite
US5009898A (en) * 1988-09-29 1991-04-23 Kabushiki Kaisha Sangi Antimicrobial hydroxyapatite powders and methods for preparing them
JP2816342B2 (en) * 1988-10-07 1998-10-27 茂 塚越 Column packing for high density lipoprotein fraction measurement
EP0376331A3 (en) * 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
SE9000650L (en) * 1989-02-28 1990-08-29 Asahi Optical Co Ltd Separation of cells or viruses
DE4042579C2 (en) * 1989-02-28 2000-11-30 Asahi Optical Co Ltd Adsorbents for sepg. cells or viruses
JPH0832551B2 (en) * 1989-06-24 1996-03-29 旭光学工業株式会社 Porous calcium phosphate-based compound particles and method for producing the same
JPH04118047A (en) * 1990-03-30 1992-04-20 Central Glass Co Ltd Adsorbent and filler for separation and refining and manufacture thereof
JPH04303766A (en) * 1991-03-30 1992-10-27 Kobe Steel Ltd Method of forming pores in surface of separation material for liquid chromatography
US5332503A (en) * 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
JP3600676B2 (en) * 1996-01-29 2004-12-15 ペンタックス株式会社 In vivo soluble composite particles
US6013591A (en) * 1997-01-16 2000-01-11 Massachusetts Institute Of Technology Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production
JP3490864B2 (en) * 1997-06-02 2004-01-26 ペンタックス株式会社 Method for producing ceramic spherical granules
AU2001244021A1 (en) * 2000-04-26 2001-11-07 Ecole Polytechnique Federale De Lausanne (Epfl) Calcium phosphate microgranules
JP4870429B2 (en) 2003-06-09 2012-02-08 Hoya株式会社 Adsorbent, adsorption device, and production method of adsorption device
CN100480177C (en) * 2004-07-28 2009-04-22 同济大学 Method for synthesizing nano hydroxy-apatite micro powder containing carbonate radical
JP5248904B2 (en) * 2008-04-18 2013-07-31 Hoya株式会社 Coated particle, method for producing coated particle, and adsorption device
JP5724050B2 (en) * 2009-09-28 2015-05-27 Hoya株式会社 Powder, powder manufacturing method, adsorption device
WO2017051400A1 (en) * 2015-09-25 2017-03-30 Clean World Technologies Ltd. Producing calcium oxides
JP2017119230A (en) 2015-12-28 2017-07-06 Jnc株式会社 Adsorbent and method for producing the same
CN109803736B (en) * 2016-09-29 2022-02-08 生物辐射实验室股份有限公司 Agarose filled ceramic apatite
JP2018002580A (en) * 2016-12-27 2018-01-11 株式会社ソフセラ Method for producing calcium phosphate sintered compact particle
CN108927113B (en) * 2018-05-22 2021-05-18 福州大学 Nano-hydroxyapatite functionalized solid phase extraction monolithic column
CN109650364B (en) * 2018-12-28 2022-05-10 武汉工程大学 Micron hexagonal-column strontium-doped hydroxyapatite and synthesis process thereof
CN115477535A (en) * 2022-09-09 2022-12-16 晞华生物科技(上海)有限公司 Ceramic hydroxyapatite for chromatography and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737516A (en) * 1971-03-05 1973-06-05 Du Pont Calcium-deficient hydroxylapatite for use in column chromatography
US4481175A (en) * 1982-12-14 1984-11-06 Mitsui Toatsu Chemicals, Inc. Process for preparing apatite
US4497075A (en) * 1979-10-08 1985-02-05 Mitsubishi Mining & Cement Co., Ltd. Filler for filling in defects or hollow portions of bones
US4711769A (en) * 1984-12-18 1987-12-08 Kanto Kagaku Kabushiki Kaisha Calcium-phosphorus-apatite having novel properties and process for preparing the same
US4743377A (en) * 1985-07-02 1988-05-10 Shiseido Company Ltd. Packing material for liquid chromatography
US4794171A (en) * 1985-09-23 1988-12-27 Toa Nenryo Kogyo Kabushiki Kaisha Calcium-phosphate type hydroxyapatite and process for producing same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60198458A (en) * 1984-03-22 1985-10-07 Koken:Kk Column for chromatography

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737516A (en) * 1971-03-05 1973-06-05 Du Pont Calcium-deficient hydroxylapatite for use in column chromatography
US4497075A (en) * 1979-10-08 1985-02-05 Mitsubishi Mining & Cement Co., Ltd. Filler for filling in defects or hollow portions of bones
US4481175A (en) * 1982-12-14 1984-11-06 Mitsui Toatsu Chemicals, Inc. Process for preparing apatite
US4711769A (en) * 1984-12-18 1987-12-08 Kanto Kagaku Kabushiki Kaisha Calcium-phosphorus-apatite having novel properties and process for preparing the same
US4743377A (en) * 1985-07-02 1988-05-10 Shiseido Company Ltd. Packing material for liquid chromatography
US4794171A (en) * 1985-09-23 1988-12-27 Toa Nenryo Kogyo Kabushiki Kaisha Calcium-phosphate type hydroxyapatite and process for producing same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Skoog et al, Fundamentals of Analytical Chemistry, Holt, Rinehart and Winston, Inc. (1963), pp. 359, 360. *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827669A (en) * 1995-11-10 1998-10-27 Mikio Nakayama Sheets, kits and methods for detecting antigens or antibodies
US5843731A (en) * 1996-09-05 1998-12-01 Asahi Kogaku Kogyo Kabushiki Kaisha Method for purifying plasmid DNA on calcium phosphate compound
US5910584A (en) * 1996-09-05 1999-06-08 Asahi Kogaku Kogyo Kabushiki Kaisha Method for isolating plasmid DNA
US5858318A (en) * 1996-11-27 1999-01-12 Luo; Ping Methods of synthesizing hydroxyapatite powders and bulk materials
US6203574B1 (en) 1998-04-14 2001-03-20 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic bone filler and process for the production of the same
US20050123652A1 (en) * 2003-12-04 2005-06-09 Kuzma William M. Method for producing tri-calcium phosphate
US20070258876A1 (en) * 2003-12-04 2007-11-08 Kuzma William M Method for producing tri-calcium phosphate
US7754174B2 (en) * 2003-12-04 2010-07-13 Natural Enrichment, LLC Method for producing tri-calcium phosphate
US20090092533A1 (en) * 2003-12-04 2009-04-09 Kuzma William M Method for producing tri-calcium phosphate
US8815328B2 (en) 2005-01-04 2014-08-26 Rutgers, The State University Of New Jersey Hydroxyapatite with controllable size and morphology
US20100040668A1 (en) * 2006-01-12 2010-02-18 Rutgers, The State University Of New Jersey Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
US8287914B2 (en) 2006-01-12 2012-10-16 Rutgers, The State University Of New Jersey Biomimetic hydroxyapatite synthesis
US20100189611A1 (en) * 2006-08-23 2010-07-29 The Clorox Company Foamable Composition Containing Alcohol
US20080221688A1 (en) * 2007-03-09 2008-09-11 Warsaw Orthopedic, Inc. Method of Maintaining Fatigue Performance In A Bone-Engaging Implant
US20080221681A1 (en) * 2007-03-09 2008-09-11 Warsaw Orthopedic, Inc. Methods for Improving Fatigue Performance of Implants With Osteointegrating Coatings
EP4218718A2 (en) 2009-05-06 2023-08-02 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2011060099A2 (en) 2009-11-10 2011-05-19 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles, and methods of making and using the same
CN103191705A (en) * 2013-04-15 2013-07-10 武汉大学 Preparation method of open tubular capillary electrochromatographic column
US20180209947A1 (en) * 2014-03-03 2018-07-26 Bioway Scientific Llc Spherical porous hydroxyapatite sorbent and methods thereof
US10914712B2 (en) * 2014-03-03 2021-02-09 Bio-Rad Laboratories, Inc. Spherical porous hydroxyapatite sorbent and methods thereof

Also Published As

Publication number Publication date
EP0217614A3 (en) 1987-09-30
ATE56198T1 (en) 1990-09-15
DE3673934D1 (en) 1990-10-11
KR880007360A (en) 1988-08-27
JPS6291410A (en) 1987-04-25
US4781904A (en) 1988-11-01
AU595238B2 (en) 1990-03-29
EP0217614B1 (en) 1990-09-05
JPH0788205B2 (en) 1995-09-27
EP0217614A2 (en) 1987-04-08
CN1013663B (en) 1991-08-28
KR910006420B1 (en) 1991-08-24
AU6300786A (en) 1987-03-26
CN86107584A (en) 1987-07-15

Similar Documents

Publication Publication Date Title
US5082566A (en) Calcium-phosphate type hydroxyapatite for chromatographic separation and process for producing same
US4794171A (en) Calcium-phosphate type hydroxyapatite and process for producing same
US5158756A (en) Porous particles of calcium phosphate compound and production process thereof
CA1166619A (en) Abrasion-resistant granular zeolite and process for preparation thereof
US5217699A (en) Calcium-phosphate type hydroxyapatite
US5707516A (en) Column packings for liquid chromatography
US4325847A (en) Use of additional alumina for extra zeolite stability in FCC catalyst
JPH0337706B2 (en)
CA1299124C (en) Biological support
US5073357A (en) Process for producing hydroxylapatites
JPH0414748B2 (en)
JPH04118047A (en) Adsorbent and filler for separation and refining and manufacture thereof
CN1958447A (en) Preparation method of high-purity silica gel
Kijima et al. Adsorption of L-asparagine and L-alanine on α-zirconium phosphate
EP0320849B1 (en) Apatite packing for liquid chromatography and process for producing the same
JPH0794396B2 (en) Method for producing aromatic hydrocarbon
JPH09175805A (en) Calcium phosphate-based hydroxyapatite for chromatographic separation and production thereof
JPS63157973A (en) Liquid chromatography
EP0342932A1 (en) Solid support and column for liquid chromatography
JPH0426508A (en) Hydroxyapatite fine crystal and its production
JPH0796445B2 (en) Hydroxyapatite secondary particle aggregate, method for producing the same, and use thereof as a chromatographic filler
JP2902274B2 (en) Separation and purification of chromatographic stationary phase materials and biologically relevant polymer samples
JPH01199155A (en) Filler for liquid chromatography
CA1312593C (en) Active material produced from metal oxide/hydroxide particles and phosphate esters
JP3352757B2 (en) Packing material for liquid chromatography

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: TONEN CORPORATION, A CORP. OF JAPAN, JAPAN

Free format text: CHANGE OF NAME AND CHANGE OF ADDRESS;ASSIGNOR:TAO NENRYO KOGYO K.K.;REEL/FRAME:008545/0151

Effective date: 19970508

AS Assignment

Owner name: ASAHI OPTICAL CO., LTD., A/K/A ASAHI KOGAKU KOGYO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TONEN CORPORATION;REEL/FRAME:009586/0135

Effective date: 19980907

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12